IGF-1 LR3 (1mg)
Extended IGF-1
IGF-1 LR3 is a long-acting variant of insulin-like growth factor with enhanced stability and bioavailability. Engineered with a 13-amino acid extension, it delivers sustained anabolic signaling for muscle growth, recovery, and metabolic optimization beyond what natural IGF-1 can achieve.
The Science
What is IGF-1 LR3?
IGF-1 LR3 (Long R3 Insulin-Like Growth Factor-1) is a synthetic analog of human IGF-1, modified with a 13-amino acid N-terminal extension that dramatically extends its half-life from minutes to 20-30 hours. This structural modification also reduces its binding affinity to IGF binding proteins, allowing it to remain bioactive in circulation significantly longer than endogenous IGF-1.
By binding directly to IGF-1 receptors on muscle cells, IGF-1 LR3 activates downstream anabolic pathways including PI3K/Akt and MAPK signaling—promoting protein synthesis, glucose uptake, cellular proliferation, and satellite cell activation. This makes it exceptionally effective for muscle growth, recovery from injury, and metabolic optimization.
Unlike growth hormone which works upstream through the GH/IGF-1 axis, IGF-1 LR3 provides direct receptor activation with sustained exposure—offering a targeted approach to anabolic enhancement. IGF-1 LR3 has been shown in research to optimize body composition, athletic performance, and recovery acceleration.
Laboratory Observations
Key Observed Effects of IGF-1 LR3 (1mg)
Accelerated Muscle Growth
Direct IGF-1 receptor activation promotes rapid muscle protein synthesis and satellite cell proliferation, supporting significant hypertrophy and strength gains beyond natural capacity.
Enhanced Recovery
Stimulates cellular repair mechanisms and reduces recovery time between training sessions, allowing for higher training frequency and faster return from injury.
Improved Body Composition
Promotes lean muscle mass while supporting fat oxidation through enhanced metabolic activity, improving muscle-to-fat ratio and overall physique aesthetics.
Metabolic Enhancement
Increases glucose uptake in muscle tissue and enhances insulin sensitivity, supporting improved nutrient partitioning and metabolic health markers.
Extended Half-Life
The 20-30 hour half-life means sustained anabolic signaling with fewer administrations compared to regular IGF-1, providing convenience and consistent results.
Reduced Binding Protein Interference
Lower affinity for IGF binding proteins means more free, bioactive IGF-1 LR3 in circulation—maximizing receptor engagement and anabolic effects.
Mechanism of Action
Direct Anabolic Signaling
IGF-1 LR3 binds directly to IGF-1 receptors on muscle and other tissues, triggering powerful anabolic cascades that promote protein synthesis, cellular growth, and metabolic enhancement with sustained activity.
IGF-1 Receptor Activation
Binds to IGF-1 receptors on muscle cells with high affinity, initiating tyrosine kinase signaling that activates critical anabolic pathways for growth and recovery.
PI3K/Akt Pathway
Activates the PI3K/Akt pathway which increases protein synthesis, glucose uptake, and cellular survival while inhibiting muscle protein breakdown.
Satellite Cell Proliferation
Stimulates muscle satellite cells to proliferate and differentiate, supporting muscle repair, hypertrophy, and the creation of new muscle fibers for enhanced growth capacity.
FAQ
Frequently Asked Questions
What makes IGF-1 LR3 different from regular IGF-1?+
IGF-1 LR3 features a 13-amino acid N-terminal extension that extends its half-life from minutes to 20-30 hours and reduces binding to IGF binding proteins. This means it stays bioactive in the system much longer, provides more sustained anabolic signaling, and requires less frequent administration compared to regular IGF-1.
When do results appear in IGF-1 LR3 studies?+
Users typically report accelerated muscle growth, enhanced recovery between training sessions, improved muscle fullness and vascularity, better nutrient partitioning, and noticeable body composition changes within 2-4 weeks. Results are maximized when combined with proper training, nutrition, and adequate protein intake. Individual responses vary based on training status, diet, and genetics.
Research-Only Notice
IGF-1 LR3 (1mg) is categorized by the FDA as for research-purposes-only. It is not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease. The information above summarizes effects observed in laboratory studies to date and is provided strictly for scientific and educational reference.